Abstract
Some of the many enzymes found in hepatocytes can be measured in the serum and are used as tests of liver function. We now review the current knowledge of their physiology and pathophysiology and outline their clinical usefulness. We divide them into two categories: enzymes that primarily reflect cholestasis, such as the alkaline phosphatase, the 5-nucleotidase, and the gamma-glutamyl transpeptidase, and those that primarily reflect hepatocellular necrosis, such as the aminotransferases. We also briefly discuss several enzymes of more limited usefulness.
Similar content being viewed by others
References
Gutman AB: Serum alkaline phosphatase activity in disease of the skeletal and hepatobiliary systems. Am J Med 27:875–901, 1959
Posen S: Alkaline phosphatase. Ann Intern Med 67:183–203, 1967
Roberts WM: Variations in the phosphatase activity in the blood in disease. Br J Exp Pathol 11:90–95, 1930
Kaplan MM: Alkaline phosphatase. Gastroenterology 62:452–468, 1972
Posen S, Neale FC, Birkett DJ, Brudenell J: Intestinal alkaline phosphatase in human serum. Am J Clin Pathol 48:81–86, 1967
Robinson JC, Goldsmith LA: Genetically determined variants of serum alkaline phosphatase: A review. Vox Sang 13:289–307, 1967
Clubb JS, Neale FC, Posen S: The behavior of infused human placental alkaline phosphatase in human subjects. J Lab Clin Med 66:493–507, 1965
Clarke LC, Beck E: Plasma “alkaline” phosphatase activity. I. Normative data for growing children. J Pediatr 36:335–341, 1950
Kattwinkel J, Taussig LM, Statland BE, Verter JI: The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr 82:234–242, 1973
Salz JL, Daum F, Cohen MI: Serum alkaline phosphatase activity during adolescence. J Pediatr 82:536–537, 1973
Birkett DJ, Done J, Neale FC, Posen S: Serum alkaline phosphatase in pregnancy: An immunologic study. Br Med J 1:1210–1212, 1966
McMaster Y, Tennant R, Clubb JS, Neale FC, Posen S: The mechanism of the elevation of serum alkaline phosphatase in pregnancy. J Obstet Gynaecol Br Emp 71:735–739, 1964
Philip JR, Grodson GM, Carbone JV: Mercaptic conjugation in the uptake and secretion of sulfobromophthalein. Am J Physiol 200:545–547, 1961
Klaassen CHL: Age and serum alkaline phosphatase. Lancet 2:1361, 1966
Heino AF, Jokipii SG: Serum alkaline phosphatase levels in the aged. Ann Med Intern Fenn 51:105–109, 1962
Deren JJ, Williams LA, Muench H, Chalmers T, Zamcheck N: Comparative study of four methods of determining alkaline phosphatase. N Engl J Med 270:1277–1283, 1964
Long CH, Ullrey DE, Miller ER: Serum alkaline phosphatase in the postnatal pig and effect of serum storage on enzyme activity. Proc Soc Exp Biol Med 119:412–414, 1965
Wolf PL: Clinical significance of an increased or decreased serum alkaline phosphatase level. Arch Pathol Lab Med 102:497–501, 1978
Kaplan MM, Rogers L: Separation of human serum alkaline phosphatase isoenzymes by polyacrylamide gel electrophoresis. Lancet 2:1029–1031, 1969
Brensilver HL, Kaplan MM: Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 68:1556–1562, 1975
Posen S, Neale FC, Clubb JS: Heat inactivation in the study of human alkaline phosphatase. Ann Intern Med 62:1234–1243, 1965
Bahr M, Wilkinson JH: Urea as a selective inhibitor of human tissue alkaline phosphatases. Clin Chim Acta 17:367–370, 1967
Kaplan MM: Understanding serum enzyme tests in clinical liver disease.In Problems in Liver Diseases. CS Davidson (ed). New York, Stratton Intercontinental Medical Book, 1979, pp 79–85
Winkelman J, Nadler S, Demetriou J, Pileggi VJ: The clinical usefulness of alkaline phosphatase isoenzyme determinations. Am J Clin Pathol 57:625–634, 1972
Connell MD, Dinwoodie AJ: Diagnostic use of serum alkaline phosphatase isoenzymes and 5-nucleotidase. Clin Chim Acta 30:236–241, 1970
Crofton PM: Biochemistry of alkaline phosphatase isoenzymes. CRC Crit Rev Clin Lab Sci 16:161–194, 1982
Kaplan MM: Serum alkaline phosphatase-another piece is added to the puzzle. Hepatology 6:526–528, 1986
Chiandussi L: Serum alkaline phosphatase fractions in hepatobiliary and bone disease. Clin Sci 22:425–434, 1962
Newton MA: The clinical application of alkaline phosphatase electrophoresis. Q J Med 36:17–28, 1967
Boernig H, et al: Zum Mekanismus der Aktivitaetsanderung der alkalinischen Phosphatase in Leber und Darm der Ratte. Acta Biol Med Ger 22:537, 1969
Kaplan MM, Righetti A: Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J Clin Invest 49:508–516, 1970
Schlaeger R, Haux P, Kattermann R: Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: Significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from the rat liver. Enzyme 28:3–13, 1982
Kaplan MM, Ohkubo A, Quaroni EG, Sze-Tu D: Increased synthesis of rat liver alkaline phosphatase by bile duct ligation. Hepatology 3:368–376, 1983
Righetti ABB, Kaplan MM: Disparate responses of serum and hepatic alkaline phosphatase and 5′-nucleotidase to bile duct obstruction in the rat. Gastroenterology 62:1034–1039, 1972
Righetti ABB, Kaplan MM: Effects of actinomycin D on rat liver alkaline phosphatase. Proc Soc Exp Biol Med 136:491–495, 1971
Seetharam S, Sussmann NL, Kimoda T, Alpers DM: The mechanism of elevated serum alkaline phosphatase activity after bile duct ligation in the rat. Hepatology 6:374–380, 1986
Hatoff DE, Hardison WGM: Induced synthesis of alkaline phosphatase by bile acids in the rat liver cell culture. Gastroenterology 77:1062–1067, 1979
Hatoff DE, Hardison WGM: Bile acids modify alkaline phosphatase induction and bile secretion pressure after bile duct obstruction in the rat during cholestasis. Gastroenterology 80:666–672, 1981
Kaplan MM, Matloff DS, Selinger MJ, Quaroni EG: Biochemical basis for serum enzyme abnormalities in alcoholic liver disease.In Early Identification of Alcohol Abuse, NIAAA Research Monograph 17. NC Chang, NM Chan (eds). US Dept of Health and Human Services, Rockville, MD, 1985, pp 186–198
Debroe ME, Borgers M, Wieme RJ: The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta 59:369–372, 1975
Debroe ME, Roels F, Nouwen EJ, Claeys L, Wieme RJ: Liver plasma membrane: The source of high molecular weight alkaline phosphatase in serum. Hepatology 5:118–128, 1985
Hatoff DE, Toyota N, Wong C, Miler AL, Takeya M, Miyai K: Rat liver alkaline phosphatase—evidence that hepatocyte and portal triad enzymes differ. Dig Dis Sci 30:564–572, 1985
Seiffert UB, Siede WH, Welsch GJ, Oremek G: Multiple forms of alkaline phosphatases in human liver tissue. Clin Chim Acta 144:17–27, 1984
Simon FR, Sutherland E: Hepatic alkaline phosphatase isoenzymes: Isolation, characterization and differential alteration. Enzyme 22:80–90, 1977
Komoda T, Kumegawa M, Yajima T, Tamura G, Alpers DH: Induction of rat hepatic and intestinal alkaline phosphatase activity produced by bile from bile duct-ligated animals. Am J Physiol 9:G393-G399, 1984
Perillo RP, Griffin R, Deschryver-Kecskemet K, Lander JJ, Zuckermann JR: Alcoholic liver disease presenting with marked elevation of alkaline phosphatase: A combined clinical and pathological study. Dig Dis Sci 23:1061–1066, 1978
Aisenberg AC, Kaplan MM, Rieder SV, Goldmann JM: Serum alkaline phosphatase at the onset of Hodgkin's disease. Cancer 26:318–326, 1970
Utz DC, Warren MM, Gregg JA, Ludwig J: Reversible hepatic dysfunction associated with hypernephroma. Mayo Clin Proc 45:161–169, 1970
Fishman WH: Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: The Regan isoenzyme. Ann NY Acad Sci 166:745–759, 1969
Wilson JW: Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med 301:983–984, 1979
Goldberg DM: 5-nucleotidase: Recent advances in cell biology, methodology and clinical significance. Digestion 8:87–99, 1973
Song CS, Kappas A: 5′-nucleotidase of plasma membranes of the rat liver: Studies on subcellular distribution. Ann NY Acad Sci 166:565–573, 1969
Arsenis C, Touster O: Purification and properties of an acid nucleotidase from rat liver lysosomes. J Biol Chem 243:5702–5708, 1968
Bailyes FM, Soos M, Jackson P, Newby AC, Sieddle K, Luzio JP: The existence and properties of two dimers of rat liver ecto-5′-nucleotidase. Biochem J 221:369–377, 1984
Fritzson P: nucleotidase activities in the soluble fraction of rat liver homogenate. Partial purification and properties of a 5′-nucleotidase with pH optimum 6.3. Biochim Biophys Acta 178:534–541, 1969
Chuang NN, Newby AC, Luzio JP: Characterization of different molecular forms of 5′-nucleotidase in normal serum and in serum from cholestatic patients and bile duct ligated rats. Biochem J 224:689–695, 1984
Helfield A, Goldberg A: Normal ranges and diagnostic value of serum hb5′-nucleotidase and alkaline phosphatase activities in infancy. Arch Dis Child 46:842–846, 1971
Hardawill C, Chang G: Serum lactic dehydrogenase, leucine aminopeptidase and 5′-nucleotidase activities: Observations in patients with carcinoma of the pancreas and hepatobiliary disease. Can Med Assoc J 89:755–761, 1963
Hill PG, Sammons HG: An assessment of 5′-nucleotidase as a liver function test. Q J Med 36:457–468, 1967
Kowlessar OD, Haeffner IJ, Riley EM, Sleisenger MH: Comparative study of serum leucine aminopeptidase, 5′-nucleotidase and nonspecific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone. Am J Med 31:231–237, 1961
Young II: Serum 5′-nucleotidase: Characterization and evaluation in disease states. Ann NY Acad Sci 75:357–362, 1958
Fritzson P: Dephosphorylation of pyrimidine nucleotides in the soluble fraction of homogenates from normal and regenerating rat liver. Eur J Biochem 1:12–20, 1967
Campbell DM: Determination of 5′-nucleotidase in blood serum. Biochem J 82:34P, 1962
Belfield A, Ellis G, Goldberg DM: A specific colorimetric 5′-nucleotidase assay utilizing the Berthelot reaction. Clin Chem 16:396–401, 1970
Price CP, Hill PG, Sammons HG: A comparison of two colorimetric procedures for the assay of 5′-nucleotidase. Clin Chim Acta 33:260–263, 1971
Belfield A, Goldberg DM: Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate. Nature 219:73–75, 1968
Kaplan MM, Kanel GC, Singer JA: Enzyme changes and morphometric analysis of bile ducts in experimental bile duct obstruction. Clin Chim Acta 99:113–119, 1979
Schenker S, Balint J, Schiff L: Differential diagnosis of jaundice: report of a prospective study of 61 proved cases. Am J Dig Dis 7:449–463, 1962
Ellis G, Goldberg D, Spooner FM: Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 70:248–258, 1978
Vinnik IE, Kern F, Corley WD: Serum 5′-nucleotidase and pericholangitis in patients with chronic ulcerative colitis. Gastroenterology 45:492–498, 1963
Eshchar J, Rudzki C, Zimmerman HJ: Serum levels of 5′-nucleotidase in disease. Am J Clin Pathol 47:598–606, 1967
Kim NK, Yasmineh WG, Freier EF, Goldman AI, Theologides A: Value of alkaline phosphatase, 5′-nucleotidase, gamma-glutamyl transferase and glutamate dehydrogenase activity measurements (single and combined) in serum diagnosis of metastases to the liver. Clin Chem 23:2034–2038, 1977
Seitanidis B, Moss DW: Serum alkaline phosphatase and 5′-nucleotidase levels during normal pregnancy. Clin Chim Acta 25:183–184, 1969
Kater RMH, Mistilis SP: Obstetric cholestasis and pruritus of pregnancy. Med J Aust 54:638–642, 1967
Kreek MJ: Cholestasis of pregnancy and during ethinyl estradiol administration in the human and rat.In Metabolic Effect of Gonadal Hormones and Contraceptive Steroids. HA Salahnick, DM Kipnis, RLVande Wiele (eds). New York, Plenum Press, 1969, pp 40–58
Goldberg DM: Structural, functional and clinical aspects of gamma-glutamyl transferase. CRC Crit Rev Clin Lab Sci 12:1–58, 1980
Meier PJ, Sztul ES, Reuben A, Boyer JL: Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J Cell Biol 98:991–1000, 1984
Wenham PR, Horn DB, Smith AF: Multiple forms of gamma-glutamyl transferase: A clinical study. Clin Chem 31:569–573, 1985
Zimmerman HJ: Evaluation of the function and integrity of the liver.In Clinical Diagnosis and Management by Laboratory Methods. JB Henry (ed). 1979, pp 305–346
Lum G, Gambino SR: Serum gamma-glutamyl transpeptidase activity as an indicator of disease of the liver, pancreas and bone. Clin Chem 18:358–362, 1972
Sczeklik E, Orlowski M, Szewczuk A: Serum gammaglutamyl transpeptidase activity in liver disease. Gastroenterology 41:353–359, 1961
Zein M, Discombe G: Serum gamma-glutamyl transpeptidase activity as a diagnostic aid. Lancet 2:748–750, 1970
Meister A: The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies. Ann Intern Med 81:247–253, 1974
Meister A: Gluthathione and the gamma-glutamyl cycle.In Glutathione: Metabolism and Function. IM Arias, WB Jakoby (eds). New York, Raven Press, 1976, p 35
Meister A, Tate SS: Glutathione and related gamma-glutamyl compounds: Biosynthesis and utilization. Annu Rev Biochem 45:559–604, 1976
Shaw LM, Neuman DA: Hydrolysis of glutathione by human liver gamma-glutamyl transferase. Clin Chem 25:75–79, 1979
Szasz G: A kinetic photometric method for serum gammaglutamyl transpeptidase. Clin Chem 15:124–136, 1969
Szasz G: Reaction rate method for gamma-glutamyl transferase activity in serum. Clin Chem 22:2051–2055, 1976
Rosalki SB, Tarlow D, Rau D: Plasma gamma glutamyl transpeptidase elevation in patients receiving enzyme inducing drugs. Lancet 2:376–377, 1971
Singh HP, Hebert MA, Gault MH: Effects of some drugs on clinical laboratory values as determined by the technicon SMA 12/60. Clin Chem 18:137–144, 1972
Whitfield JB, Pounder RE, Neale G, Moss DW: Serum gamma-glutamyl tidase activity in liver disease. Gut 13:702–708, 1972
Whitfield JB, Moss DW, Neale J, Orme M, Breckenridge A: Changes in gamma-glutamyl transferase activity associated with alterations in drug metabolism in man. Br Med J 1:316–318, 1973
Harouki R, Chobert MN, Finidori J, Aggerbeck M, Nalpas B, Hanoune J: Ethanol effects in a rat hepatoma cell line: Induction of gamma-glutamyl transferase. Hepatology 3:323–329, 1983
Lamy J, Bagliss MC, Ferrant JP, Weill J: Determination de la gamma-glutamyl transpeptidase des ethyliques a la suite du sevrage. Clin Chim Acta 56:169–173, 1974
Rollason JG, Pinkerle G, Robinson D: Serum gammaglutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 39:75–80, 1972
Rosalki S, Rau D: Serum gamma-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39:41–47, 1972
Westwood M, Cohen MI, McNamara H: Serum gammaglutamyl transpeptidase activity: A chemical determinant of alcohol consumption during adolescence. Pediatrics 62:560–562, 1978
Whitehead TP, Clarke CA, Whitfield AGW: Biochemical and haematological markers of alcohol intake. Lancet 1:978–981, 1978
Ivanov E, Adjarov D, Etarska M, Stankushev T, Brum barov K, Kerimova M: Elevated liver gamma-glutamyl transferase in chronic alcoholics. Enzyme 25:304–308, 1980
Selinger MJ, Matloff DS, Kaplan MM: Gamma-glutamyl transpeptidase activity in liver disease: Serum elevation is independent of hepatic GGTP activity. Clin Chim Acta 125:283–290, 1982
Huseby NE, Torstein V: The activity of gamma-glutamyl transferase after bile duct ligation in guinea pig. Clin Chim Acta 88:385–392, 1978
Betro MG, Oon RCS, Edwards JB: Gamma-glutamyl transpeptidase in diseases of the liver and bone. Am J Clin Pathol 60:672–678, 1973
Ideo G, Morganti A, Dioguardi N: Gamma-glutamyl transpeptidase: A clinical and experimental study. Digestion 5:326–336, 1972
Rutenburg AM, Goldbarg JA, Pineda EP: Serum gammaglutamyl transpeptidase activity in hepatobiliary and pancreatic disease. Gastroenterology 45:43–48, 1963
Walker FB, Hobbit DL, Cunningham FG, Combes B: Gamma-glutamyl transpeptidase in normal pregnancy. Obstet Gynecol 43:745–749, 1974
Burrows S, Feldman W, McBride F: Serum gamma-glutamyl transpeptidase: Evaluation in screening of hospitalized patients. Am J Clin Pathol 64:311–314, 1975
Combes B, Shore GM, Cunningham FG, Walker FB, Shorey JW, Ware A: Serum gamma-glutamyl transpeptidase activity in viral hepatitis: Suppression in pregnancy and by birth control pills. Gastroenterology 72:271–274, 1977
Rutenburg AM, Goldbarg JA, Pineda EP: Leucine aminopeptidase activity: Observations in patients with cancer of the pancreas and other diseases. N Engl J Med 259:469–472, 1958
Kowlessar OD, Haeffner IJ, Sleisenger MH: Localization of leucine aminopeptidase in serum and body fluids by starch gel electrophoresis. Am J Med 31:231–237, 1961
Banks BM, Pineda EP, Goldbarg JA, Rutenburg AM: Clinical value of serum leucine aminopeptidase determinations. N Engl J Med 263:1277–1281, 1960
Pruzanski W, Fischl J: The evaluation of serum leucine aminopeptidase estimation: The influence of the administration of steroids on S-LAP activity in obstructive disease of the biliary tract (preliminary report). Am J Med Sci 248:581–587, 1964
Bressler R, Forsyth BR: Serum leucine aminopeptidase activity in normal pregnancy and in patients with hydatidiform mole. N Engl J Med 261:746–748, 1959
Rutenburg AM, Banks BM, Pineda EP, Goldbarg JA: A comparison of serum aminopeptidase and alkaline phosphatase in the detection of hepatobiliary disease in anicteric patients. Ann Intern Med 61:50–55, 1964
Rutenburg AM, Pineda EP, Goldberg JA, Levitan R, Gellis SS, Silverberg M: Serum leucine aminopeptidase activity: In normal infants, in biliary atresia and in other diseases. Am J Dis Child 103:47–54, 1962
Bressler R, Forsyth BR, Klatskin G: Serum leucine aminopeptidase activity in hepatobiliary and pancreatic disease. J Lab Clin Med 56:417–430, 1960
De Ritis F, Giusti G, Piccinino F, Cacciatore L: Biochemical lab tests in viral hepatitis and other hepatic diseases. Bull WHO 32:59–72, 1965
Wrobleski F: The clinical significance of transaminase activities in serum. Am J Med 27:911–923, 1959
Zimmerman HJ, West M: Serum enzyme levels in the diagnosis of hepatic disease. Am J Gastroenterol 40:387–404, 1963
Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E: Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 86:632–636, 1984
Rej R: Aspartate aminotransferase activity and isoenzyme proportion in human liver tissues. Clin Chem 24:1971–1979, 1978
Boyde TRC, Latner AL: Starch gel electrophoresis of transaminases in human tissue extracts and serum. Biochem J 82:51P, 1962
Morino Y, Kagamiyama H, Wada H: Immunochemical distinction of glutamic oxaloacetic transaminases from soluble and mitochondrial fractions of mammalian tissues. J Biol Chem 239:943–944, 1964
Rej R: Measurement of aminotransferase; Part 1: Aspartate aminotransferase. CRC Crit Rev Clin Lab Sci 21:99–186, 1985
Kamimoto Y, Horiuchi S, Tanase S, Morino Y: Plasma clearance of intravenously injected aspartate aminotransferase isozymes: Evidence for preferential uptake by sinusoidal liver cells. Hepatology 5:367–375, 1985
Dunn M, Martins J, Reissmann KR: The disappearance rate of glutamic oxaloacetic transaminase from the circulation and its distribution in the body fluid compartments and secretions. J Lab Clin Med 51:259–265, 1958
Frankl HD, Merritt JH: Enzyme activity in the serum and common duct bile of dogs. Am J Gastroenterol 31:166–170, 1959
De Ritis F, Coltorti M, Giusti G: Transaminase activity in liver disease. Lancet 2:214–215, 1958
Clermont RJ, Chalmers TC: The transaminase tests in liver disease. Medicine 46:197–207, 1967
Matloff DS, Selinger MJ, Kaplan MM: Hepatic transaminase activity in alcoholic liver disease. Gastroenterology 78:1389–1392, 1980
Cohen JA, Kaplan MM: The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979
Abbruzzese A, Jeffrey RL: Marked elevation of serum glutamic oxaloacetic transaminase and lactic dehydrogenase activity in chronic extrahepatic biliary disease. Am J Dig Dis 14:332–338, 1969
Dreyfus JC, Schapira G, Schapira F: Serum enzymes in the physiopathology of muscle. Ann NY Acad Sci 75:235–249, 1959
De Ritis F, Coltorti M, Giusti G: Serum transaminase activities in liver disease. Lancet 1:685–687, 1972
Gerety RJ (ed): Non-A, Non-B Hepatitis. New York, Academic Press, 1981
Soloway RD, Summerskill WHJ, Baggenstoss AH, Geall MG, Gitnick GL, Elveback LR, Schoenfied LJ: Clinical, biochemical and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology 63:820–833, 1972
Franklin M, Bean WB, Paul WD, Routh JI, Huerga JDL, Popper H: Electrophoretic studies in liver disease. II. Gammaglobulin in chronic liver disease. J Clin Invest 30:729–737, 1951
Sabath LD, Gerstein DA, Finland M: Serum glutamic oxaloacetic transaminase. False elevation during administration of erythromycin. N Engl J Med 279:1137–1139, 1968
Young DS, Thomas DW, Friedman RD, Pestaner LI: Effects of drugs on clinical lab tests. Clin Chem 18:1041–1042, 1972
Warnock LG, Stone WJ, Wagner L: Decreased aspartate aminotransferase (“SGOT”) activity in serum of uremic patients. Clin Chem 20:1213–1216, 1974
Panteghini M, Falsetti F, Chiari E, Malchiodi A: Determination of aspartate isoenzymes in hepatic diseases—preliminary findings. Clin Chim Acta 128:133–140, 1983
Nalpas B, Varsault A, Le Guillou A, Lacour B, Berthelot P: A new marker of chronic alcoholism: Serum mitochondrial aspartate amino-transferase.In Early Identification of Alcohol Abuse, NIAAA Research Monograph 17. NC Chang, NM Chan (eds). US Dept of Health and Human Services, Rockville, MD, 1985, pp 94–99
Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P: Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 6:608–614, 1986
Nishimura T, Yoshida Y, Watanabe F, Koseki M, Nishida T, Tagawa K, Kawashima Y: Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver. Hepatology 6:701–707, 1986
Remmer AR Jr, Kaljot V: Serum transaminase levels. Effects of strenuous and prolonged physical exercise on healthy young subjects. JAMA 185:968–970, 1963
Wolf PL: Lactate dehydrogenase-6: A biochemical sign of serious hepatic circulatory disturbance. Arch Intern Med 145:1396–1397, 1985
Rosalki SB: Enzyme tests in diseases of the liver and hepatobiliary tract.In The Principles and Practice of Diagnostic Enzymology. JH Wilkinson (ed). London, Edward Arnold, 1973, pp 303–360
Schmidt F, Schmidt FW: Methode und Wert der Bestimmung der Glutaminsaure-Dehydrogenawe Aktivitaet in Serum. Klin Wochenschr 40:962–969, 1962
Okumura M, Spellberg MA: Serum isocitric dehydrogenase activity in the differential diagnosis of liver disease. Gastroenterology 39:305–311, 1960
Sterkel RL, Spencer JA, Wolfson SK, Williams-Ashman HG: Serum isocitric dehydrogenase activity with particular reference to liver disease. J Lab Clin Med 52:176–184, 1958
West M, Schwartz MA, Cohen J, Zimmerman HJ: Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of the kidney, prostate and urinary bladder. Cancer 17:432–437, 1964
Guder WG, Habicht A, Kleissl J, Schmidt U, Witland OH: The diagnostic significance of liver cell inhomogeneity: Serum enzymes in patients with central liver necrosis and the distribution of glutamic dehydrogenase in normal human liver. Z Klin Chem Klin Biochem 13:311–318, 1975
Svoboda DJ, Manning RT: Chronic alcoholism with metamorphosis of the liver. Mitochondrial alterations in hepatic cells. Am J Pathol 44:645–652, 1964
Van Waes, Lieber CS: Glutamate dehydrogenase: A reliable marker of liver cell necrosis in the alcoholic. Br Med J 2:1508–1510, 1977
Jenkins WJ, Rosalki SB, Foo Y, Scheuer PJ, Nemsanszky E, Sherlock S: Serum glutamate dehydrogenase is not a reliable marker of liver cell necrosis in alcoholics. J Clin Pathol 35:207–210, 1982
Jung K, Pergandi M, Rej R, Schreiber G, Schimmelpfennig W: Mitochondrial enzymes in human serum: comparative determinations of glutamate dehydrogenase and mitochondrial aspartate aminotransferase in healthy persons and patients with chronic liver diseases. Clin Chem 31:239–243, 1985
Mills PR, Spooner RJ, Russell RI, Boyle P, MacSween RNM: Serum glutamate dehydrogenase as a marker of hepatocyte necrosis in alcoholic liver disease. Br Med J 283:754–755, 1981
Reichard H: Ornithine carbamyl transferase activity in human serum in diseases of the liver and biliary system. J Lab Clin Med 57:78–87, 1961
Konttinen A: Multiple serum enzyme analysis in chronic alcoholics. Acta Med Scand 188:257–264, 1970
Deshmuk DH, Rittenhouse JW, Mason M, Baublis JW: Serum ornithine carbamyl transferase activities in Reye's syndrome. Enzyme 27:45–51, 1982
Deshmuk DH, Thomas PE, McArthur B, Sarnaik AP: Serum glutamate dehydrogenase and ornithine carbamyl transferase in Reye's syndrome. Enzyme 33:171–174, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reichling, J.J., Kaplan, M.M. Clinical use of serum enzymes in liver disease. Digest Dis Sci 33, 1601–1614 (1988). https://doi.org/10.1007/BF01535953
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01535953